US FDA Limits Use of J&J’s Covid-19 Vaccine Over Blood Clot Risk
On Thursday, 5th May 2022, the Food and Drug Administration (FDA) of the United States had been limiting the use of the corona virus vaccine of Johnson & Johnson for the adult people because of the risk of a rare blood clotting syndrome. The corona virus vaccine shot of Johnson & Johnson, which has now […]
Continue Reading